Additional use of DNA-image cytometry improves the assessment of resection margins.

Jörg Handschel, Döne Oz, Natalia Pomjanski, Rita Depprich, Michelle A Ommerborn, Stefan Braunstein, Norbert R Kübler, Ulrich Meyer, Alfred Böcking

Department for Cranio- and Maxillofacial Surgery, Heinrich-Heine-University, Düsseldorf, Germany.

Journal Article: Journal of Oral Pathology and Medicine (impact factor: 2.14). 10/2007; 36(8):472-5. DOI: 10.1111/j.1600-0714.2007.00564.x

Abstract

BACKGROUND: Despite the histopathologic findings of tumor-free margins, patients with oral squamous cell carcinoma (SCC) often suffer from local tumor relapse. The purpose of this study was to determine the prognostic value of DNA-image cytometry in the assessment of resection margins. METHODS: DNA-image cytometry was performed in 40 SCC patients with histologically tumor-free resection margins. The follow-up period since the tumor resection was at least 3 years. RESULTS: Twenty patients showed a locoregional relapse of the SCC. Fourteen of these patients had aneuploid cells in DNA-image cytometry. Two patients who were relapse-free revealed aneuploid cells too. The sensitivity of the adjuvant use of DNA-image cytometry was 70% and the positive predictive value was 87.5%. CONCLUSIONS: The additional use of DNA-image cytometry is a reasonable tool for the assessment of the resection margins of SCCs. DNA-image cytometry could help to find the appropriate treatment option for the patients and thus might improve their prognosis.

Source: PubMed

Comments on this publication

ResearchGate members can add comments. Sign up now and post your comment!

Similar publications

Science & Research Jobs

Keywords

40 SCC patients
 
additional use
 
adjuvant use
 
aneuploid cells
 
appropriate treatment option
 
DNA-image cytometry
 
follow-up period
 
histologically tumor-free resection margins
 
histopathologic findings
 
local tumor relapse
 
locoregional relapse
 
oral squamous cell carcinoma
 
patients
 
resection margins
 
SCC
 
SCCs
 
tumor resection
 
tumor-free margins